GEORGE BAKER: Open Payments
NPI 1467404905 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 25 payments from 11 companies in 2025. Trend: 2023 $1,021 · 2024 $716 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $84 |
| GlaxoSmithKline, LLC. | 5 | $84 |
| Lilly USA, LLC | 3 | $80 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
| Medtronic, Inc. | 1 | $16 |
Products named: XIFAXAN, TRELEGY ELLIPTA, JARDIANCE, GARDASIL 9, Ozempic, Rybelsus, KISUNLA, GEMTESA.
Industry payments across FL — which companies pay providers there.
